Sympathetic interventions are frequently used in complex regional pain syndrome (CRPS). However, the evidence is inconclusive, and the response may depend on phenotype, anatomical target, and treatment durability. For upper-extremity CRPS, clinical data on thoracic sympathetic block (TSB) with botulinum toxin type A (BoNT-A) are lacking.
Keywords: Botulinum toxin, Case series, Complex regional pain syndrome, Interventional pain management, Sympathetic block
Interventional pain medicine
Journal Article
English
42238955
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.